arrow
V

Valerio Nardone

precision medicine
H指数:27
被引数:2,456

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients

基于血液的MAVS生物传感器在预测SCLC患者免疫治疗反应中的临床应用概念验证研究

2026-04-040
OAAI
Seeing More to Treat Better: Ultra-High Frequency Ultrasound as a Decision-Shaping Tool in Radiotherapy for Head and Neck Non-Melanoma Skin Cancer in a Single-Institution Feasibility Study

看得更多,治疗更好:单机构可行性研究中,超高频超声作为头颈非黑色素瘤皮肤癌放射治疗的决策塑造工具

Cancers
IF4.4
2026-04-030
OAAI
Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study

细胞因子在经立体定向放射治疗的寡转移性非小细胞肺癌中的作用:一项观察性试点研究

2026-03-130
OAAI
High prevalence of loss of Claudin-18 expression in invasive non-mucinous lung adenocarcinoma: Potential diagnostic implications in routine practice

浸润性非黏液性肺腺癌中Claudin-18表达缺失的高发生率:在常规实践中的潜在诊断意义

2026-03-120
OAAI
Radiotherapy in Italian media: (mis)information, patients’ perception and medical career choices

意大利媒体中的放射疗法:(误)信息、患者认知及医学职业选择

2025-12-030
OAAI
Delta-Radiomics Biomarker in Colorectal Cancer Liver Metastases Treated with Cetuximab Plus Avelumab (CAVE Trial)

Delta-Radiomics生物标志物在经西妥昔单抗联合阿维单抗治疗结直肠癌肝转移中的应用(CAVE试验)

2025-11-190
OAAI
Advancing Non-Small-Cell Lung Cancer Management Through Multi-Omics Integration: Insights from Genomics, Metabolomics, and Radiomics

通过多组学整合推进非小细胞肺癌管理:来自基因组学、代谢组学和放射组学的见解

2025-10-140
OAAI
“Aging and epigenetic implications in radiotherapy: The promise of BNCT”

“老龄化与放疗中的表观遗传学意义:硼中子俘获疗法(BNCT)的潜力”

2025-05-300
OA
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer

DNA-PK 抑制可维持小细胞肺癌的先天抗肿瘤免疫反应。

2025-03-010
OAAI
Previous radiotherapy increases the efficacy of cemiplimab in the treatment of locally advanced and metastatic cutaneous squamous cell carcinoma: A retrospective analysis
2024-10-010
OA